GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WGS GeneDx Holdings

Closed Good Friday 04-17 16:00:00 EDT

95.47

-2.81

-2.86%

盘后95.75

+0.28+0.29%

19:27 EDT

High97.78	Low92.92	Vol622.40K
Open97.32	D1 Closing98.28	Amplitude4.94%
Mkt Cap2.68B	Tradable Cap1.77B	Total Shares28.07M
T/O59.11M	T/O Rate3.36%	Tradable Shares18.51M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":95.47,"timestamp":1744920000000,"preClose":98.28,"halted":0,"volume":622396,"hourTrading":{"tag":"盘后","latestPrice":95.75,"preClose":95.47,"latestTime":"19:27 EDT","volume":14822,"amount":1415279,"timestamp":1744932465186},"delay":0,"floatShares":18505101,"shares":28068274,"eps":-1.944352,"marketStatus":"Closed Good Friday","change":-2.81,"latestTime":"04-17 16:00:00 EDT","open":97.32,"high":97.782,"low":92.923,"amount":59113055.9336,"amplitude":0.04944,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.944352,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":98.28,"preHourTrading":{"tag":"盘前","latestPrice":98.2,"preClose":98.28,"latestTime":"09:23 EDT","volume":852,"amount":83790.20412,"timestamp":1744896187591},"postHourTrading":{"tag":"盘后","latestPrice":95.75,"preClose":95.47,"latestTime":"19:27 EDT","volume":14822,"amount":1415279,"timestamp":1744932465186},"volumeRatio":0.815893776192865,"impliedVol":1.4877,"impliedVolPercentile":0.9681},"requestUrl":"/m/hq/s/WGS","defaultTab":"news","newsList":[{"id":"2528106534","title":"GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2528106534","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528106534?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 20:01","pubTimestamp":1744977704,"startTime":"0","endTime":"0","summary":"Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. Changing trade, monetary, and fiscal policies increased volatility in US stocks. The emergence of artificial intelligence  models from China added to the uncertainty. Against this backdrop, the class A shares of the fund underperformed the Russell 2000 Growth Index. The Communication Services and Energy sectors contributed to the relative performance of the fund in the quarter, while the Health Care and Information Technology sectors detracted. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2025.In another article, we covered GeneDx Holdings Corp.  and shared the list of high growth low debt stocks to invest in. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-holdings-corp-wgs-rose-120144966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","TQQQ","NQmain","QID","MNQmain","TSYW.SI","WGS","WGSWW","USAW.SI","QLD","USJW.SI","BK4196","PSQ","NVIW.SI",".IXIC"],"gpt_icon":1},{"id":"2527260880","title":"GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale","url":"https://stock-news.laohu8.com/highlight/detail?id=2527260880","media":"Business Wire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527260880?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 18:00","pubTimestamp":1744797600,"startTime":"0","endTime":"0","summary":"Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to genomic information. Accelerates the NICU, enables newborn screening, and opens global market opportunities with on-site sequencing and decentralized interpretation. GAITHERSBURG, Md. & OAKLAND, Calif., April 16, 2025----GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced its plans to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation. The transaction enables GeneDx’s leadership in the next phase of genomic medicine: decentralized testing with centralized intelligence.\"This marks an exciting new chapter for Fabric Genomics. By joining forces with GeneDx, we’re combining two of the most powerful engines in genomic medicine, our AI-driven interpretation platform and GeneDx’s unparalleled rare disease data set,\" said Martin Rees","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-acquire-fabric-genomics-enabling-100000335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WGS","WGSWW"],"gpt_icon":0},{"id":"2525189184","title":"Press Release: GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525189184","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525189184?lang=en_us&edition=full_marsco","pubTime":"2025-04-08 20:19","pubTimestamp":1744114740,"startTime":"0","endTime":"0","summary":"GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the first quarter of 2025 before the market opens on Wednesday, April 30, 2025. Management will host a conference call that day to discuss first quarter 2025 financial and operating results at 8:30 a.m. Eastern Time.At GeneDx , we believe that everyone deserves personalized, targeted medical care--and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2524259814","title":"GeneDx expands into Inborn Errors of Immunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2524259814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524259814?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 20:10","pubTimestamp":1743682239,"startTime":"0","endTime":"0","summary":"GeneDx (WGS) announced the commercial expansion into Inborn Errors of Immunity, a group of nearly 500 genetic disorders that impair immune function...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genedx-expands-into-inborn-errors-of-immunity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genedx-expands-into-inborn-errors-of-immunity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2524255225","title":"GeneDx Expands Commercial Footprint for Exome and Genome Testing With Inborn Errors of Immunity as a New Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2524255225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524255225?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 20:00","pubTimestamp":1743681602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nTUABF0YZ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2524593192","title":"GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2524593192","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524593192?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 20:00","pubTimestamp":1743681600,"startTime":"0","endTime":"0","summary":"Focus on Inborn Errors of Immunity expands access to exome and genome testing for the known 200,000+ patients in the US 1 impacted by these conditions and opens new opportunities for GeneDx and biopharma partners to accelerate the path to treatment for patients. With an expanded commercial focus on IEIs, GeneDx accelerates patient care with the adoption of exome and genome testing, empowering ordering clinicians with more accurate and comprehensive genetic insights to better treat this patient population. Today, clinicians treating IEIs recognize the importance of genetic testing, and with the rapid pace of new gene-disease discovery in IEI1, exome and genome sequencing are better equipped than panel-based testing to stay up to date with new discoveries in this area. Genomic sequencing provides a diagnostic yield of approximately 40% for IEI patients3,4,5 — higher than the 29% yield from multi-gene panels.3. \"Inborn Errors of Immunity can be difficult to diagnose based on clinical","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-expands-commercial-footprint-exome-120000385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4585","WGSWW","BK4196","IEI","WGS"],"gpt_icon":0},{"id":"2524413966","title":"Buy 3 Momentum Anomaly Stocks as Markets Rise Despite Tariff Threats","url":"https://stock-news.laohu8.com/highlight/detail?id=2524413966","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524413966?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 21:33","pubTimestamp":1743600780,"startTime":"0","endTime":"0","summary":"Percentage Change in Price  = Top #50: This selects the top 50 stocks with the best percentage price change over the last 52 weeks. This parameter ensures we get the best stocks that have appreciated steadily over the past year.Percentage Change in Price  = Bottom #10: From the above 50 stocks, we then choose those that are also among the 10 worst performers over a short one-week period. This parameter picks the ones that have witnessed a short-term pullback in price.Zacks Rank #1: Stocks sporting a Zacks Rank #1  have a proven history of outperformance irrespective of the market conditions. You can see the complete list of today’s Zacks #1 Rank stocks here.MomentumStyle Score of B or Better: A top Momentum Style Score knocks out a lot of the screening process as it takes into account several factors that include volume change and performance relative to its peers. It indica","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/buy-3-momentum-anomaly-stocks-133300159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4608","BK4196","WGSWW","BK4023","BK4588","BK4539","BK4613","BK4577","WGS","BK4076","BK4547","GME","APP"],"gpt_icon":1},{"id":"2522470825","title":"3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522470825","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522470825?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 01:07","pubTimestamp":1742836077,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a surge amid reports of potential tariff adjustments, investors are keenly observing opportunities that may arise from these developments. In this fluctuating environment, identifying stocks estimated to be trading at a discount can offer potential value for those looking to capitalize on market inefficiencies.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Operations: The company generates revenue through its Gene Dx segment, contributing $302.29 million, and its Legacy Sema4 segment, which adds $3.16 million.GeneDx Holdings, trading at US$104.39, is considered undervalued with an estimated fair value of US$139.61 based on discounted cash flow analysis. Recent initiatives include the launch of Multiscore, an AI-powered tool enhancing genetic diagnostics efficiency and expanding testing for cerebral palsy patients. Despite past volatility in share price, GeneDx's revenue is expected to grow faster than the mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-stocks-estimated-trading-discount-170757773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","BK4548","BK4588","BK4130","LU1878469433.USD","IE00BLDYK493.USD","BK4545","BK4167","LU1720051108.HKD","LU1861214812.USD","LU1974910355.USD","DAY","LU2023250504.SGD","LU2517655374.HKD","BK4198","WGSWW","LU1861219969.SGD","LU1169590202.USD","WGS","LU1803068623.USD","LU0205194284.USD","LU0106261612.USD","HCM","LU1548497426.USD","BK4153","LU2517655291.USD","BK4585","LU1720051017.SGD","LU1815336091.USD","LU2357305700.SGD","CSTM","LU1917777945.USD","LU0205193047.USD","WAY","LU1244550494.USD","LU2106854487.HKD","LU2517655028.SGD","ASB","BK4531","ALB","LU1244550221.USD","IE00B64QTZ34.USD","BHLB","BK4007","LU2249611893.SGD","BK4109","LU1169589451.USD","LU0012050646.USD","LU1244550577.SGD","HAE","LU0757428866.USD"],"gpt_icon":0},{"id":"2521479112","title":"Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521479112","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521479112?lang=en_us&edition=full_marsco","pubTime":"2025-03-23 05:48","pubTimestamp":1742680102,"startTime":"0","endTime":"0","summary":"We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look at where GeneDx Holdings Corp.  stands against other high growth low debt stocks to invest in now.The global financial markets are experiencing heightened volatility, influenced by a confluence of economic and geopolitical factors. The broader markethas entered correction territory, reflecting investor apprehension regarding escalating trade tensions and potential economic slowdowns.The recent imposition of tariffs by the United States has been a significant catalyst for market fluctuations. In response, major indices such as the broader market and Nasdaq Composite have experienced notable declines. This environment has led to a reassessment of investment strategies, with a growing emphasis on asset quality and financial resilience.While debt can be a useful tool for fueling growth, excessive debt levels can pose significant risks. High debt-to-equity (D/E) rati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-holdings-wgs-high-growth-214822594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WGS","TQQQ","NVIW.SI","NQmain","TSYW.SI","USJW.SI","SQQQ","BK4196","WGSWW","QID","MNQmain","USAW.SI",".IXIC","QLD","PSQ"],"gpt_icon":1},{"id":"2521491452","title":"BRIEF-GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521491452","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521491452?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:52","pubTimestamp":1742503944,"startTime":"0","endTime":"0","summary":"BRIEF-GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 20 (Reuters) - GeneDx Holdings Corp WGS.O:GENEDX REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw14tjhgaFurther company coverage: WGS.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA4BLQB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2521604496","title":"GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521604496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521604496?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:05","pubTimestamp":1742501101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA4BLQB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2520624448","title":"Is Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520624448","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520624448?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 19:26","pubTimestamp":1742297215,"startTime":"0","endTime":"0","summary":"While GeneDx Holdings Corp.  might not have the largest market cap around , it received a lot of attention from a substantial price increase on the NASDAQGS over the last few months. While good news for shareholders, the company has traded much higher in the past year. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain?Let’s examine GeneDx Holdings’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. In terms of investment risks, we've identified 1 warning sign with GeneDx Holdings, and understanding this should be part of your investment process.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/now-time-look-buying-genedx-112655973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","IE00BGHQF748.EUR","PSQ","TQQQ","BK4112","MNQmain","IE00B3QW5Z07.USD","IE00BKPKM429.USD","USJW.SI","QID","SQQQ","NQmain","WGSWW","NDAQ","TSYW.SI","USAW.SI","BK4588","LU2210149790.SGD","BK4196","LU2095319765.USD",".IXIC","WGS","LU2210150020.SGD","NVIW.SI","BK4585","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2520283623","title":"Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2520283623","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520283623?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 19:05","pubTimestamp":1742295900,"startTime":"0","endTime":"0","summary":"GeneDx recognized for its innovative approach to accelerating genetic diagnosis and transforming the future of healthcare by ending the diagnostic odyssey. GAITHERSBURG, Md., March 18, 2025----GeneDx , a leader in delivering improved health outcomes through genomic insights, announced today they have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025, and recognized as the No. 2 in the Biotech category. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of the economy.As the driving force behind scaling precision medicine, GeneDx is revolutionizing whole genome sequencing  to deliver faster, more accurate diagnoses to patients. With industry-leading innovations, GeneDx has slashed WGS turnaround time to as little as 48 hours, ensuring that critical answers reach patients and their families with unprecedented spe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fast-company-recognizes-genedx-one-110500104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BYQQ9H92.USD","BK4196","IE00BFXG0V08.USD","WGS","BK4588","BK4104","FAST","BK4585","WGSWW","BK4567","IE00B5TLWC47.USD"],"gpt_icon":0},{"id":"2520264948","title":"BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520264948","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520264948?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 17:57","pubTimestamp":1742291875,"startTime":"0","endTime":"0","summary":"BTIG analyst Mark Massaro maintained a Buy rating on GeneDx Holdings (WGS – Research Report) yesterday and set a price target of $115.00. The compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-sticks-to-its-buy-rating-for-genedx-holdings-wgs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-sticks-to-its-buy-rating-for-genedx-holdings-wgs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS"],"gpt_icon":0},{"id":"2520264756","title":"5 Stocks With Recent Price Strength Amid Extreme Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2520264756","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520264756?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 17:48","pubTimestamp":1742291280,"startTime":"0","endTime":"0","summary":"U.S. stock markets have been enduring severe volatility over the past month. Wall Street’s recent turmoil is broad-based. The three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — are in the negative territory year to date. The S&P 500 and the Nasdaq Composite are in fact, in a correction zone. Moreover, the mid-cap-centric S&P 400 is in the red and the small-cap benchmark Russell 2000 is in the bear territory, year to date.If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.Here’s how you should create the screen to shortlist the current as well as the potential winners.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-stocks-recent-price-strength-094800847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0501845795.SGD","LU1267930227.SGD","LU0251143458.SGD","LU1048596156.SGD","BK4196","LU1152091168.USD","LU0067412154.USD","BK4587","IE00BFMHRM44.USD","LU1242518857.USD","BK4575","WGSWW","BK4107","BABA","BK4534","LU1105468828.SGD","IE00B7SZL793.SGD","BK4585","IE00B0JY6N72.USD","LU1688375341.USD","BK4077","IE00B66KJ199.SGD","DRD","BK4504","BK4502","LU0348814723.USD","LU2226246903.HKD","BK4538","BK4558","EVER","HBBD.SI","09988","HCI","BK4017","BK4543","LU0310800965.SGD","LU1046422090.SGD","LU1048588211.SGD","BK4220","LU0918141887.USD","LU1046421795.USD","BK4526","LU0797268264.HKD","LU0918141705.HKD","LU0072913022.USD","COMP","BK4524","BK4579","LU0052756011.USD","BK4548","WGS","BK4581","IE00B19Z4B17.USD"],"gpt_icon":1},{"id":"2520576486","title":"Is GeneDx Holdings (NASDAQ:WGS) Using Too Much Debt?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520576486","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520576486?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 19:26","pubTimestamp":1742210773,"startTime":"0","endTime":"0","summary":"Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/is-genedx-holdings-nasdaqwgs-using-too-much-debt-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B3QW5Z07.USD","PSQ","TQQQ","MNQmain","LU2095319765.USD","LU2210150020.SGD","EBIT","NVIW.SI",".IXIC","TSYW.SI","IE00BGHQF748.EUR","BK4588","BK4196","SQQQ","USJW.SI","WGS","NQmain","BK4585","IE00BKPKM429.USD","BK4112","QID","LU2210149790.SGD","IE00B64PRP62.GBP","USAW.SI","NDAQ","QLD"],"gpt_icon":1},{"id":"2519789309","title":"Is GeneDx Holdings Corp. (WGS) the Best Multibagger Stock to Buy in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519789309","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519789309?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 07:00","pubTimestamp":1741906800,"startTime":"0","endTime":"0","summary":"We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at where GeneDx Holdings Corp.  stands against other best multibagger stocks to buy in 2025.READ ALSO:12 Best Multibagger Penny Stocks to Buy Now. The aforementioned developments have caused a market selloff, particularly in previously high-momentum stocks such as the Magnificent 8, which have benefited from the AI megatrend and were responsible for most of the market returns last year. Prior to that, many previously well-performing stocks, such as government contractors, had already lost their momentum following the election results, while some of the few well-performing healthcare stocks were hit by Medicare/Medicaid reimbursement threats. Likewise, the energy sector remained somewhat out of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-holdings-corp-wgs-best-230000810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","USJW.SI",".IXIC","USAW.SI","WGS","PSQ","QID","TQQQ","QLD","WGSWW","TSYW.SI","NVIW.SI","BK4196","NQmain","SQQQ"],"gpt_icon":1},{"id":"2519839699","title":"GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2519839699","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519839699?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 20:30","pubTimestamp":1741869000,"startTime":"0","endTime":"0","summary":"GeneDx's Multiscore tool to be showcased at the American College of Medical Genetics and Genomics  Annual Meeting. GAITHERSBURG, Md., March 13, 2025----GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support tool designed to revolutionize genetic analysis by improving diagnostic efficiency, streamlining workflows, and enhancing clinical insights. Multiscore is embedded into GeneDx’s interpretation platform as a decision support tool to help clinical geneticists focus on the most relevant genes during their clinical analysis. GeneDx will present the AI-powered decision support tool at ACMG, in a session: Multiscore, a Gene Ranker Powered by Artificial Intelligence and Real-World Clinical Data, Shows High Sensitivity in 10,000 Exomes and Genomes which received one of the limited spots in an industry-specific platform session.At GeneDx , we believe that everyone deserves personalized, targeted m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-enhances-power-interpretation-platform-123000658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4543","BK4587","BK4084","WGS","WGSWW","AI","BK4528","BK4196","BK4588","PW","BK4234","BK4023","BK4551"],"gpt_icon":0},{"id":"2519583969","title":"GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2519583969","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519583969?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 20:30","pubTimestamp":1741869000,"startTime":"0","endTime":"0","summary":"Presentations to highlight how GeneDx is leveraging AI to drive both better patient care and scale. GAITHERSBURG, Md., March 13, 2025----GeneDx , a leader in delivering improved health outcomes through genomic insights, announced today its scientific contributions will be presented at the 2025 American College of Medical Genetics and Genomics  Annual Clinical Genetics Meeting. GeneDx will showcase its leadership in genomic research and innovation, driving the industry forward with three platform presentations and two poster presentations.GeneDx earned one of the limited spots available for an industry-specific platform presentation on its AI-powered gene ranker embedded in its interpretation platform to enhance the speed and efficiency of clinical analysis. Through the combination of GeneDx’s industry leading proprietary dataset, publicly available data, and the power of AI, Multiscore prioritizes genes with positive findings in exome and genome sequences by ranking them based on align","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-showcase-key-research-innovation-123000608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4166","AFG","WGSWW","BK4107","WGS","BK4117","PT","BK4196"],"gpt_icon":0},{"id":"2518222973","title":"Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222973","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518222973?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 21:22","pubTimestamp":1741612944,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Emerging Technology Stocks to Buy Now.In this article, we are going to take a look at where GeneDx Holdings Corp.  stands against the other emerging technology stocks.The technology sector is constantly evolving, with emerging technology companies leading the charge in groundbreaking innovations. From quantum computing and artificial intelligence  to biotechnology and autonomous systems, these companies are reshaping industries and unlocking new economic opportunities. Emerging technology firms focus on disruptive advancements that have the potential to transform traditional markets. These businesses operate across various fields, including AI, quantum computing, genomics, space technology, and robotics.AI remains the Driving Force Behind Emerging Technologies","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-holdings-corp-wgs-best-132224903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","USJW.SI","WGS","USAW.SI","BK4196","QID","WGSWW","TQQQ","NVIW.SI","NQmain","TSYW.SI","SQQQ",".IXIC","MNQmain","PSQ"],"gpt_icon":1}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":0.0308},{"period":"1month","weight":0.0515},{"period":"3month","weight":0.3741},{"period":"6month","weight":0.5898},{"period":"1year","weight":9.3772},{"period":"ytd","weight":0.2421}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.176826},{"month":2,"riseRate":1,"avgChangeRate":0.457595},{"month":3,"riseRate":0.2,"avgChangeRate":-0.132973},{"month":4,"riseRate":0.4,"avgChangeRate":0.061509},{"month":5,"riseRate":0.25,"avgChangeRate":-0.033789},{"month":6,"riseRate":0.5,"avgChangeRate":-0.037543},{"month":7,"riseRate":0.75,"avgChangeRate":0.146466},{"month":8,"riseRate":0,"avgChangeRate":-0.237867},{"month":9,"riseRate":0.25,"avgChangeRate":-0.04851},{"month":10,"riseRate":0.75,"avgChangeRate":0.168214},{"month":11,"riseRate":0,"avgChangeRate":-0.217721},{"month":12,"riseRate":0.4,"avgChangeRate":-0.012987}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction